These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31739657)

  • 21. Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes.
    Santharam S; Tampourlou M; Arlt W; Ayuk J; Gittoes N; Toogood A; Webster R; Karavitaki N
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):508-514. PubMed ID: 28626987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
    Colao A; Sarno AD; Cappabianca P; Briganti F; Pivonello R; Somma CD; Faggiano A; Biondi B; Lombardi G
    Eur J Endocrinol; 2003 Mar; 148(3):325-31. PubMed ID: 12611613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1562-7. PubMed ID: 26256063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstrual Cycle Abnormalities in Patients with Prolactinoma and Drug-induced Hyperprolactinemia.
    Kulshreshtha B; Pahuja I; Kothari D; Chawla I; Sharma N; Gupta S; Mittal A
    Indian J Endocrinol Metab; 2017; 21(4):545-550. PubMed ID: 28670538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotroph adenoma of the pituitary mimicking a prolactinoma.
    Yamada S; Horvath E; Kovacs K; Aiba T; Shimizu T; Shishiba Y; Hara M
    Neurosurgery; 1991 Mar; 28(3):444-8; discussion 448-9. PubMed ID: 2011231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anejaculation as the presenting feature of pituitary microadenoma.
    Nair S; Milsom S
    Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cluster headache and macroprolactinoma: Case report of a rare, but potential important causality.
    Andereggen L; Mono ML; Kellner-Weldon F; Christ E
    J Clin Neurosci; 2017 Jun; 40():62-64. PubMed ID: 28209309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.
    Levine SN; Ishaq S; Nanda A; Wilson JD; Gonzalez-Toledo E
    Ann Diagn Pathol; 2013 Aug; 17(4):361-6. PubMed ID: 23602507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.
    Larouche V; Correa JA; Cassidy P; Beauregard C; Garfield N; Rivera J
    Pituitary; 2016 Apr; 19(2):202-9. PubMed ID: 26700946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of prolactinomas during pregnancy.
    Witek P; Zieliński G
    Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy.
    Garcia MM; Kapcala LP
    J Endocrinol Invest; 1995 Jun; 18(6):450-5. PubMed ID: 7594240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant Prolactinoma Presenting with Neck Pain and Structural Compromise of the Occipital Condyles.
    Yecies D; Ajlan A; Ratliff J; Ziskin J; Hwang P; Vogel H; Katznelson L; Harsh G
    J Neurol Surg Rep; 2015 Nov; 76(2):e297-301. PubMed ID: 26623246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of prolactinomas: a survey of physicians from the Middle East and North Africa.
    Beshyah SA; Sherif IH; Chentli F; Hamrahian A; Khalil AB; Raef H; El-Fikki M; Jambart S
    Pituitary; 2017 Apr; 20(2):231-240. PubMed ID: 27783196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Giant prolactinomas: are they really different from ordinary macroprolactinomas?
    Espinosa E; Sosa E; Mendoza V; Ramírez C; Melgar V; Mercado M
    Endocrine; 2016 Jun; 52(3):652-9. PubMed ID: 26561015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.
    Zhou WJ; Ma SC; Zhao M; Liu C; Guan XD; Bao ZS; Jia GJ; Jia W
    Asian J Androl; 2018; 20(1):43-49. PubMed ID: 28816201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.
    Barausse M; Attanasio R; Dallabonzana D; Oppizzi G; Veronese S; Lasio G; Valentini LG; Cozzi R
    J Endocrinol Invest; 2000 Feb; 23(2):107-11. PubMed ID: 10800764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fertility in prolactinomas--considerations concerning some clinical cases].
    Ionescu O; Vulpoi C; Ungureanu MC; Ionescu D; Zbranca E
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):806-9. PubMed ID: 12092244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.